Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 180
2
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can personalized medicine subtype bladder cancer?

Molecular pathoepidemiology is the study of the cause and natural history of disease on a molecular, individual...

Can we noninvasively measure blood sugar for diabetes?

Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

How Do Fats Help Us Treat Brain Cancer?

Malignant Brain Tumors will kill over 13,000 cancer patients this year in the United States alone; brain tumors...

Backer Badge Funded